What Smartwatch Glucose Tracking Really Means Today
Smartwatch glucose tracking refers to wearables such as watches and rings that show blood sugar information, usually by connecting to a separate continuous glucose monitor, rather than measuring glucose independently through their own sensors. This distinction between display and direct measurement is the core reason smartwatches still lag behind dedicated glucose devices. As TechRepublic explains, no major consumer smartwatch or smart ring can directly measure blood sugar, and the FDA has warned that it has not authorized any wearable to estimate glucose on its own. Instead, devices like Apple Watch, Samsung Galaxy Watch, Garmin wearables, and Oura Ring pull data from approved continuous glucose monitors, which use small sensors under the skin. That setup makes the watch a convenient window into glucose trends, but the continuous glucose monitor remains the real medical device.
Dexcom CONNECT: Why CGMs Set the Clinical Gold Standard
Dedicated continuous glucose monitors hold a commanding lead because they are backed by strong clinical data. Dexcom’s CONNECT randomized controlled trial showed that using the Dexcom G7 continuous glucose monitor led to clinically and statistically significant reductions in HbA1c and improved glucose control for people with Type 2 diabetes not using insulin, compared with routine care using finger-stick meters. According to Dexcom, CONNECT is “the first and only level A evidence demonstrating strong benefit of CGM for the Type 2 non-insulin using population,” a grade that often shapes treatment standards. The study found benefits across age, gender, ethnicity, baseline A1C, body mass index, education level, income, and insurance coverage, and even reported additional HbA1c reductions when Dexcom G7 was combined with medications such as metformin, GLP-1s, and SGLT2s. This depth of evidence is what smartwatch glucose tracking currently lacks.
Apple Watch, Samsung, Garmin, Oura: Displays, Not Glucose Sensors
The main smartwatch brands are racing to be part of diabetes management wearables, but they all depend on external sensors. TechRepublic notes that Apple Watch cannot measure glucose on its own; instead, it can connect directly to systems like Dexcom G7 so users can view readings without a nearby phone. Samsung’s Galaxy Watch and Garmin devices follow a similar pattern, expanding health features while still relying on approved continuous glucose monitors for any actual glucose values. Oura Ring goes a step further on coaching: it uses the Dexcom Stelo Glucose Biosensor worn on the upper arm, then combines those readings with sleep, activity, and meal logs to show patterns after eating or during daily routines. In every case, the smartwatch or ring handles visualization and context, while the continuous glucose monitor remains responsible for real-time sensing.
The Convenience Gap: Why CGM vs Smartwatch Still Favors CGMs
From a user’s point of view, smartwatch glucose tracking sounds like it should replace sensors and finger sticks, but current systems do not deliver that convenience. Apple Watch, Samsung, Garmin, and Oura all require users to wear or maintain a separate continuous glucose monitor, such as Dexcom G7 or Dexcom’s Stelo biosensor, for any real glucose data. That means an extra device on the arm and ongoing sensor changes, even though the watch or ring is what people see every day. The promise of an all-in-one wearable is still future tense. In CGM vs smartwatch comparisons, the CGM continues to carry the clinical workload: it reads interstitial glucose continuously, manages alerts, and serves as the primary tool for adjusting medication and lifestyle, while the smartwatch plays a supporting role as a convenient, but optional, display.
Clinical Proof vs Wellness Insights: Where Smartwatches Fall Short
Dedicated CGMs sit in a medical category with randomized trials and outcome data, while smartwatch glucose features remain closer to wellness coaching. Dexcom’s CONNECT trial, alongside earlier studies, positions CGMs as tools that improve HbA1c, time in range, and hyperglycemia, and may influence formal standards of care. In contrast, Apple Watch, Galaxy Watch, Garmin wearables, and Oura Ring do not have peer-reviewed evidence showing that their glucose visualizations alone, independent of the CGM, change health outcomes. Oura’s integration with Dexcom Stelo can highlight patterns after meals, connect food logs to glucose responses, and explain effects from exercise or stress, which is useful for behavior change. Still, the clinical benefit is anchored in the continuous glucose monitor’s accuracy and validation, not in the smartwatch interface. Until wearables can measure glucose directly and prove outcome benefits, CGMs will remain the reference device.
